January 8, 2021 — For decades now, we’ve been talking lots about preventing childhood obesity, but not doing much. Could it be that a shift is beginning? Two papers this week tell us this is possible. For too long, we’ve drawn an arbitrary line between obesity treatment and prevention. But the truth is that for women having children, the […]
January 1, 2021 — In a world of divisions, one sentiment seems to unite us: joy in being done with 2020. Thus we say that we look to this new year with a measure of hope for better days ahead. Even for a stern realist, hope is important. Monica Hesse explains: I am not a superstitious person and I […]
December 29, 2020 — For decades now, childhood obesity care has been on the back burner because of a false dichotomy. All efforts have gone into prevention – a noble and elusive goal. But in the face of earnest efforts to prevent childhood obesity, the prevalence has relentlessly climbed. Meanwhile, the children affected – now roughly six million with […]
December 10, 2020 — News from Eli Lilly and Company suggests that we may soon see a new drug that offers two-for-one efficacy – a clinical benefit in both obesity and diabetes. The company announced yesterday that tirzepatide produced good results against endpoints for both diseases in a phase 3 RCT. In this study, called SURPASS-1, researchers tested three […]
December 8, 2020 — What we have here is a bit of a love-hate story. In the midst of the COVID pandemic, Britain’s NHS has received an outpouring of love. But for folks living with obesity in the UK, it’s a little harder to find some of that love. Our own research suggests that some of the strongest weight […]
December 7, 2020 — Friday marked an important milestone in progress toward better treatments for obesity. Novo Nordisk submitted semaglutide to FDA for approval in treating obesity. So we may see approval for this important new drug in the second half of next year. Why so important? We have two reasons. A Step Forward in Effectiveness The first reason […]
December 6, 2020 — Looking back, treating obesity has often been framed in terms of weight loss. But looking forward, we see much more emphasis on health gain. This is certainly evident in the new Canadian obesity treatment guidelines. A new analysis from the Teen LABS study gives us further reason to look beyond weight loss in bariatric surgery. […]
December 5, 2020 — Late on Friday, Novo Nordisk announced FDA approval for Saxenda (liraglutide 3mg) to treat obesity in teens. This marks the second such drug approved in for youth in little more than a week. Setmelanotide received approval last week for children as young as six. Make no mistake about it, we are making progress in expanding […]
December 4, 2020 — Type 2 diabetes can be a brutal disease. It often, but not always, goes hand in hand with obesity. Thus, both of these conditions are rising throughout the world, exacting a terrible toll on human health. Once again, though, research tells us that a good option exists to turn this back for many people. A […]
November 29, 2020 — The coronavirus pandemic has put a spotlight on obesity because it is clearly a risk factor for worse outcomes. But now it’s becoming ever more clear that patients have options. A new study from the Cleveland Clinic suggests that bariatric surgery may cut the risk of hospitalization from COVID-19 by half or more. The lead […]
